Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,494,151 | 8,494,151 | 0 | $459.96M | $331.87M | 25.13% | -$128.09M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,406,534 | 4,101,992 | +695,458 | $90.95M | $90.24M | 6.83% | -$710.6K |
| BridgeBio Pharma, Inc.(BBIO) | 1,600,000 | 2,000,000 | +400,000 | $43.90M | $69.14M | 5.23% | +$25.24M |
| Arcellx Inc COMMON STOCK | 1,300,000 | 1,050,000 | -250,000 | $99.70M | $68.88M | 5.22% | -$30.82M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,693,219 | 1,745,000 | +51,781 | $130.31M | $66.08M | 5.00% | -$64.23M |
| Newamsterdam Pharma Company ORDINARY SHARES | 3,250,000 | 2,825,000 | -425,000 | $83.53M | $57.83M | 4.38% | -$25.70M |
| Janux Therapeutics, Inc.(JANX) | 2,100,000 | 2,000,000 | -100,000 | $112.43M | $54.00M | 4.09% | -$58.43M |
| EyePoint, Inc.(EYPT) | 8,325,000 | 8,325,000 | 0 | $62.02M | $45.12M | 3.42% | -$16.90M |
| Insmed Incorporated(INSM) | 650,000 | 525,000 | -125,000 | $44.88M | $40.05M | 3.03% | -$4.82M |
| Bright Minds Biosciences Inc.(DRUG) | 1,059,331 | 1,059,331 | 0 | $38.16M | $38.21M | 2.89% | +$53.0K |
| Helix Acquisition Corp IiCL A | 2,909,000 | 2,909,000 | 0 | $30.54M | $32.87M | 2.49% | +$2.33M |
| Centessa Pharmaceuticals PlcADS | 2,561,600 | 2,261,600 | -300,000 | $42.91M | $32.52M | 2.46% | -$10.38M |
| Merus N V | 740,000 | 740,000 | 0 | $31.12M | $31.15M | 2.36% | +$29.6K |
| Rapport Therapeutics, Inc.(RAPP) | 2,940,921 | 2,940,921 | 0 | $52.17M | $29.50M | 2.23% | -$22.67M |
| Axsome Therapeutics, Inc.(AXSM) | 325,000 | 250,000 | -75,000 | $27.50M | $29.16M | 2.21% | +$1.66M |
| Pharvaris N V COM | 1,466,460 | 1,466,460 | 0 | $28.11M | $23.02M | 1.74% | -$5.09M |
| GH Research PLC(GHRS) | 593,043 | 2,009,482 | +1,416,439 | $4.15M | $22.16M | 1.68% | +$18.01M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,825,000 | 1,350,000 | -475,000 | $25.42M | $21.11M | 1.60% | -$4.31M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 500,000 | 400,000 | -100,000 | $27.68M | $20.55M | 1.56% | -$7.14M |
| ARS Pharmaceuticals, Inc.(SPRY) | 500,000 | 1,600,000 | +1,100,000 | $5.28M | $20.13M | 1.52% | +$14.85M |
| Crinetics Pharmaceuticals In | 1,000,000 | 600,000 | -400,000 | $51.13M | $20.12M | 1.52% | -$31.01M |
| CG Oncology, Inc.(CGON) | 775,000 | 775,000 | 0 | $22.23M | $18.98M | 1.44% | -$3.25M |
| Cargo Therapeutics Inc | 1,182,563 | 3,381,277 | +2,198,714 | $17.05M | $13.76M | 1.04% | -$3.29M |
| ABIVAX Société AnonymeADS(ABVX) | 2,130,000 | 2,130,000 | 0 | $15.59M | $13.31M | 1.01% | -$2.28M |
| Alumis Inc | 2,147,396 | 2,147,396 | 0 | $16.88M | $13.19M | 1.00% | -$3.69M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,375,000 | 2,375,000 | 0 | $28.02M | $12.61M | 0.95% | -$15.41M |
| Avidity Biosciences Inc | 1,050,000 | 400,000 | -650,000 | $30.53M | $11.81M | 0.89% | -$18.73M |
| Metsera Inc | 0 | 400,000 | +400,000 | $0 | $10.89M | 0.82% | +$10.89M |
| Engene Holdings Inc COM | 2,323,595 | 2,323,595 | 0 | $15.45M | $10.41M | 0.79% | -$5.04M |
| BioAge Labs, Inc.(BIOA) | 2,629,529 | 2,629,529 | 0 | $15.22M | $9.89M | 0.75% | -$5.34M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 400,000 | 150,000 | -250,000 | $22.39M | $7.95M | 0.60% | -$14.45M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 1,837,739 | 1,837,739 | 0 | $15.80M | $7.90M | 0.60% | -$7.90M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 3,570,872 | 0 | $13.85M | $7.61M | 0.58% | -$6.25M |
| Korro Bio, Inc.(KRRO) | 0 | 380,303 | +380,303 | $0 | $6.62M | 0.50% | +$6.62M |
| Vaxcyte, Inc.(PCVX) | 425,000 | 175,000 | -250,000 | $34.79M | $6.61M | 0.50% | -$28.18M |
| Aardvark Therapeutics Inc | 0 | 800,189 | +800,189 | $0 | $6.01M | 0.45% | +$6.01M |
| MBX Biosciences, Inc.(MBX) | 700,000 | 700,000 | 0 | $12.90M | $5.17M | 0.39% | -$7.74M |
| Enliven Therapeutics Inc | 250,000 | 250,000 | 0 | $5.63M | $4.92M | 0.37% | -$705.0K |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 3,000,000 | +3,000,000 | $0 | $4.05M | 0.31% | +$4.05M |
| KALA BIO, Inc.(KALA) | 603,027 | 603,027 | 0 | $4.19M | $3.46M | 0.26% | -$729.7K |
| Stoke Therapeutics, Inc.(STOK) | 254,161 | 254,161 | 0 | $2.80M | $1.69M | 0.13% | -$1.11M |
| Biohaven Ltd.(BHVN) | 55,539 | 10,000 | -45,539 | $2.07M | $240.4K | 0.02% | -$1.83M |
| ArriVent BioPharma, Inc.(AVBP) | 585,462 | 0 | -585,462 | $15.60M | $0 | — | -$15.60M |
| Artiva Biotherapeutics, Inc.(ARTV) | 103,633 | 0 | -103,633 | $1.04M | $0 | — | -$1.04M |
| ImmunityBio, Inc.(IBRX) | 3,000,000 | 0 | -3,000,000 | $7.68M | $0 | — | -$7.68M |
| Omeros Corporation(OMER) | 300,000 | 0 | -300,000 | $2.96M | $0 | — | -$2.96M |
| Rapt Therapeutics Inc | 200,000 | 0 | -200,000 | $316.0K | $0 | — | -$316.0K |
| Septerna, Inc.(SEPN) | 560,000 | 0 | -560,000 | $12.82M | $0 | — | -$12.82M |
| UroGen Pharma Ltd.(URGN) | 300,000 | 0 | -300,000 | $3.19M | $0 | — | -$3.19M |
| Verve Therapeutics Inc | 350,000 | 0 | -350,000 | $1.97M | $0 | — | -$1.97M |
| Yarrow Bioscience Inc(YARW) | 1,394,336 | 0 | -1,394,336 | $4.67M | $0 | — | -$4.67M |
| Y-Mabs Therapeutics Inc | 425,000 | 0 | -425,000 | $3.33M | $0 | — | -$3.33M |